Venture firms back NZ-based biotech company

New Zealand-based biotechnology company CoDa Therapeutics has raised $20 million of venture capital funding. It is the latest example of increased venture appetite for biotech companies in the region.

ByJo Nash

4 January 2013•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

North America Western Europe

Venture firms back NZ-based biotech company

Domain Associates

Related articles